Target intelligence / Profile preview

Pollen allergen Phl p 5 (Phl p 5)

Target
Phl p 5
Molecular classification
Group V allergen, Four-helix-bundle domain protein
01

Overview

The pollen allergen Phl p 5 from *Phleum pratense* (timothy grass) is a major respiratory allergen recognized by IgE antibodies in 65-90% of grass pollen-allergic individuals, making it a key marker for genuine sensitization alongside Phl p 1. This small protein (approximately 29-38 kDa) features a unique structure with two domains forming a protease-resistant four-helix bundle, high alanine content (26 mol%), and multiple independent conformational IgE epitopes—up to four clusters—that explain its potent ability to trigger severe allergic symptoms like rhinitis and asthma. Isoforms such as Phl p 5a, Phl p 5b, Phl p 5.0101, and Phl p 5.0201 show structural variations, including differences in N- and C-terminal epitopes, leading to individual patient reactivity patterns and cross-reactivity with other Pooideae grasses. While not a therapeutic target like receptors or enzymes, Phl p 5 serves in diagnostics and allergen immunotherapy, with recombinant forms used to map epitopes and assess sensitization. Its high-density IgE recognition underscores challenges in desensitization therapies due to epitope diversity and histamine-releasing potency.

Other names
Phl p VGroup 5 allergenPhl p 5aPhl p 5bPhl p 5.0101Phl p 5.0201Phl p 5.0207
02

Biological functions

AllergenicityIgE bindingInduction of allergic responses
03

Disease associations

Allergic rhinitisAsthmaGrass pollen allergyRespiratory allergy
04

Safety considerations

High allergenic potency leading to severe symptomsMultiple IgE epitopes increasing cross-reactivity risk
05

Biomarkers

IgE reactivity to Phl p 5 for grass pollen allergy diagnosis

Beyond the preview

Go deeper on Pollen allergen Phl p 5 (Phl p 5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pollen allergen Phl p 5 (Phl p 5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call